RESULTS INTRODUCTION METHODS CONCLUSION  Extended spectrum beta-lactamases producing Enterobacteriacae (ESBLPE) have become a major cause of hospital-acquired.

Slides:



Advertisements
Similar presentations
East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
Advertisements

Prevalence of Staphylococcus aureus on the Door Handles of Assisted Living versus Independent Living Resident’s Rooms in a Retirement Facility Benson,
Case discussion Michael Gardam University Health Network.
Antibiotic treatment choices for SBP Treviso 8 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of Padova.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
Topical oropharyngeal vancomycin to control methicillin resistant Staphylococcus aureus lower airway infection in ventilated patients L. Silvestry et al.
Antibiogram in Washoe County Nevada – Know the Local Data, Prevent Antimicrobial Resistance Lei Chen, Ph.D., Senior Epidemiologist, Washoe County.
Epidemiological evidence for a protective role for statins in Community Acquired Pneumonia British Thoracic Society Winter Meeting 2012, London Yana Vinogradova.
MANUAL on ALERT ORGANISM SURVEILLANCE
APIC Chapter 13 Journal Club April 15, 2015
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Preventing Multidrug-Resistant Organisms (MDROs) What the Direct Caregiver Should Know Prepared by: Ann Bailey, RNC, BSN, CIC Joanne Dixon, RN, MN, CIC.
Standard and Expanded Precautions
Cleaning in the ICU: strong evidence, strong convictions and a dose of reality? Cleaning in the ICU: strong evidence, strong convictions and a dose of.
CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.
1 Can the strict search-and-isolate strategy for controlling the spread of highly-resistant bacteria be mitigated? G Birgand a, I Lolom a, E Ruppe b, L.
TEMPLATE DESIGN © Prevalence of educational qualifications and access to information technologies in patients with acute.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
1 Extended spectrum B-lactamase producing E.coli in the community and in hospital Dr Graham Harvey Consultant Microbiologist Director of Infection Prevention.
Antimicrobial Stewardship
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
1 Economic and medical adverse effects of a national policy to control the spread of highly-resistant micro-organisms. G Birgand a, M Schwarzinger b, A.
Enterovirus D68 Illness in Hospitalized Children under 24 Months of Age Kayla B. Briggs 1, Rangaraj Selvarangan 2, Ferdaus Hassan 2, Mary Anne Jackson.
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
Systematic review + meta-analysis: 69 (quasi-)randomised trials: N=7,863 pts with sepsis: any BL monoTx vs any combination of BL + AG: N (studies) : same.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Clinical and bacterial characteristics in Danish adults with pleural empyema Karin Armbruster, Christian Niels Meyer, Michael Kemp, Trine Rolighed Thomsen,
ST ELEVATION MYOCARDIAL INFARCTION (STEMI) PATIENT DISCHARGE INSTRUCTION CHECKLIST: CAN WE DO BETTER? Maryann Rabusic-Wiedener, Shauna Johns, Tina Ainsworth,
Hospital Based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis Among European Children Younger than 5 Years of Age Johannes Foster, Alfredo.
RESULTS INTRODUCTION METHODS CONCLUSION  Since the early 90’s Enterococcus faecium resistant to Glycopeptides (GRE) have emerged in several French hospitals.
ASSESSING THE FEASIBILITY OF ANTIBIOTIC MANAGEMENT SERVICES THROUGH PROSPECTIVE EVALUATION ABSTRACT PURPOSE: The inappropriate and unnecessary use of antibiotics.
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
A Survival Comparison between HIV+ U.S.-born Latinos and Foreign-born Latinos in Houston, Texas Raouf Arafat, MD, MPH, Adebowale Awosika- Olumo.
Nosoref: a French survey of nosocomial infections (NI) surveillance in intensive care units (ICU) F L’Hériteau 1, C Alberti 2, G Troché 3, P Moine 4, Y.
MRSA on Ward 29 University Hospital Aintree (UHA) April 2006-August 2010 Zoe Greenwood February 2011.
Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia? Eur J Haematol Feb. R2 이 홍 주.
Multi-Resistant Gram Negative Microorganisms St Elisabeth Hospital Curacao.
1 A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital DIABETES Care; Aug 2006; 29,8 : FM R1 임혜원.
Extended-Spectrum-β-Lactamase producing Enterobacteriaceae in neonates and association with maternal urine cultures. Alex Guri 1, Natalie Flaks-Manov 2,
Clinical Infectious Diseases 2012;55(6):764–70 Jan Vydra,1 Ryan M. Shanley,2 Ige George,1 Celalettin Ustun,1 Angela R. Smith,4 Daniel J. Weisdorf,1 and.
Timing of Post-discharge Venous Thromboembolic Events and Effect of Pharmacologic Prophylaxis in Hospitalized Patients Paul J. Grant MD, Todd Greene PhD,
JAMA Internal Medicine May 2015 Volume 175, Number5 R1 조한샘 / Prof. 이창균.
Changing Epidemiology of Adult Bacterial Meningitis in Southern Taiwan: A Hospital-Based Study Infection 2008; 36: 15–22 W.-N. Chang, C.-H. Lu, C.-R. Huang,
How I deal with an outbreak? Prof Bertrand SOUWEINE Medical ICU Clermont-Ferrand France ISICEM March 2009.
MRSA: To isolate or not to isolate? Jean-François TIMSIT, MD PhD Medical ICU, University hospital Grenoble, France INSERM U 578 ESICM Barcelona – Sept.
1 R1 임준욱 Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation.
Outcomes of Carbapenem-Resistant K. pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies Gopi Patel, MD; Shirish Huprikar, MD;
Northern Dimension Antibiotic Resistance Study NoDARS Prof Jaana Vuopio, M.D., Ph.D., PAC 11 side-event, 19 November 2015, Berlin, Germany.
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
Pr Jean-Ralph Zahar Infection Control Unit
MRSA Regina Livshits RN MSN NYU Langone Medical Center
Antibiotics: handle with care!
Etiology of bacteremia in children under 5 years in Southern Mali
High Fecal Carriage of Antibiotic Resistant Enterobacteriaceae Strains among Food Handlers in the West Coast Region of The Gambia Bakary Sanneh1*, Olliemattou.
Average susceptibility
CRE prevalence among patients with no prior history of carriage
Introduction Materials and methods Results Conclusions
Managing repeated screening for known CPE carriers: once positive always positive? Siddharth Mookerjee, Eleonora Dyakova, Frances Davies, Kathleen Bamford,
Antibiotics: handle with care!
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
The ‘bed location lottery’: the MDRO status of the prior bed occupant affects the risk of acquisition Jon Otter, PhD Scientific Director, Healthcare, Bioquell.
Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission Siddharth Mookerjee,1 Eleonora Dyakova,1 Frances.
Changes to 10A NCAC 41A May 5, 2018.
Cost utility of alternative Carbapenemase
The challenges of multi-drug-resistance in hepatology
Overseas travel and antibiotic use are more important than community demographics or measures of social and material deprivation in predicting ESBL colonization.
Neonatal sepsis in Kilifi
Cessation of screening for intestinal carriage of extended-spectrum β-lactamase- producing Enterobacteriaceae in a low-endemicity intensive care unit with.
Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent.
Presentation transcript:

RESULTS INTRODUCTION METHODS CONCLUSION  Extended spectrum beta-lactamases producing Enterobacteriacae (ESBLPE) have become a major cause of hospital-acquired infections.  Consequences: -limitation of effective antimicrobial drug therapy - adverse patient outcome  Since last decade, ESBL-PE carrying CTX-M enzymes have spread in the community  Hospitalization of asymptomatic colonized patient from the community may serve as reservoir for further cross-transmission to other hospitalized patients  The objectives of this study were to: evaluate the duration of ESBL-PE carriage after hospital discharge factors associated with clearance of ESBLPE carriage  Importation of ESBLPE in hospital settings from the community constitute a starting point for their spread to nearby patients  ESBLPE carriers had long length of hospital stay with a high risk of readmission within 30 days after hospital discharge 2  The difference median time to ESBLPE clearance with 2 previous study (198 days vs 98 and 136 days) were probably due to the populations studied and the strategy of follow- up 3,4  Associations between time of clearance and length of hospital stay > 7 days could be explained by the use of carbapenem which could decrease the gut colonization.  The association with the period of positivity could be explained the shorter follow-up during the last years of study  The long time persistence of ESBLPE carriage after hospital discharge make the screening and contact- isolation precautions at readmission advisable for all patients identified positive during an earlier hospital stay with the help of an automatic alert system.  Prospective surveillance of ESBLPE colonizations/infections from 1st January 1997 to 31 December 2010 in a 1000-bed University Hospital  Data collection: Demographical, Microbiological data and Hospital stay characteristics on ESBLPE colonizations/infections were prospectively collected  Population studied: newly admitted patient known as colonized and/or infected during a previous hospitalization identified by an automatic alert system 1 oSystematic contact-isolation precautions o Rectal swabbing if readmission > 3 months after a previous hospital discharge  Clearance : 1 negative rectal screening at the time of the readmission  Imported cases: carriage discovered within 48 h and infection within 72 h after admission,  Duration of carriage: difference between date of positive readmission and date of hospital discharge following the first positive culture  Microbiological techniques: Culture on Drigalski lactose agar and ChromID ESBL for ESBLPE screening. Susceptibility: agar diffusion method + synergy test  Data analysis: Univariate (Wilcoxon rank-sum test, 2- tailed Fischer’s exact tests) and a multivariate analysis (Cox model)  ESBL-PE was isolated from 1884 patients cumulating 2734 hospital admissions and 220 visits mainly in medical units for 2239 (41.4%), ICUs for 1699 (31%) and surgical units for 941 (17%)  ESBL-PE was imported in 951 (50.5%) and acquired in 924 (49%)  Median time to colonization: 16 days [9 - 29]  ESBL-PE strains isolated: E.coli, 1093 (51.9%); K.pneumoniae, 438 (20.8%); Enterobacter spp., 423 (20.1%).  Incidence of ESBL-PE: from 0.11 in 1997 to 0.98/1,000 Patients/days in  503 readmitted patients with a median delay of 27 days (10 – 67) after hospital discharge  449 patients screened: 181 (40.3%) ESBL positive culture and 268 (59.7%) negative.  Median time of ESBL clearance: 6.6 months (4.3 – 14.6)  Variables associated with a shorter duration of clearance (Table 1): o a first positive culture during the period , HR;95% CI= 1.65 [ ] o a length of hospital stay >7 days after a previous positive culture, 1.51 ( ) 51st ICAAC, th of September 2011, Chicago 1.Pittet D, Safran E, Harbarth S, et al. Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: role of a hospital information system. Infect Control Hosp Epidemiol 1996;17: Westert GP, Lagoe RJ, Keskimaki I, Leyland A, Murphy M. An international study of hospital readmissions and related utilization in Europe and the USA. Health Policy 2002;61: Apisarnthanarak A, Bailey TC, Fraser VJ. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2008;46: Zahar JR, Lanternier F, Mechai F et al. Duration of colonisation by Enterobacteriaceae producing extended-spectrum beta-lactamase and risk factors for persistent faecal carriage. J Hosp Infect May;75(1):76-8. Duration of Colonization by Extended Spectrum β-Lactamase producing Enterobacteriaceae after Hospital Discharge G Birgand 1, L Armand-Lefevre 2,3, I Lolom 1, E Ruppe 2,3, A Andremont 2,3, JC Lucet 1 1 Infection control unit, Bichat-Claude Bernard hospital, Paris, France 2 Bacteriology laboratory 3 EA 3964 University Paris 7, Paris France. The duration of digestive colonization with extended spectrum β-lactamase producing enterobacteriacae (ESBLPE) may play a major role in their spread. We evaluated the duration of and factors associated with clearance of ESBLPE carriage in the hospital setting. Retrospective study based on a 14-year ( ) prospective surveillance of inpatients (Pts) colonized with ESBLPE in a 1000-bed University Hospital. An automatic alert system identified readmitted Pts with a history of ESBLPE, and readmission screening was recommended. Pts were considered cleared from ESBLPE after one negative rectal sample, and the absence of new positive clinical sample during the stay. Demographic, hospital stay and microbiological data and outcome were prospectively collected. We performed survival analysis; variables associated with clearance of ESBLPE were estimated with a Cox model. A total of 1884 Pts (2734 admissions) were included. The incidence of ESBLPE in clinical isolates increased from 0.11 (K. pneumoniae, 42.4%) in 1997 to 0.98/1000 Pts.day (E. coli, 54.7%) in Species carrying the ESBLs (n=2102) were E. coli (1093 Pts, 51.9%), Enterobacter spp. (438, 20.8%) and K. pneumoniae (423, 20.1%) in clinical samples of 1221 Pts (65%) and/or in screening samples of 1086 (58%). Detection occurred ≥72 hours after admission in 924 (49%) Pts. 448 (24%) Pts had 1 to 16 readmissions, and 180 (40%) were persisting carriers. The median time of ESBLPE clearance was 6.6 months. Independent variables associated with clearance were a length of stay >7 days after a previous positive culture (aHR, 1.51; 95%CI, ), and the first positive culture during (1.65, ). There was no difference between the type of enterobacteriaceae. An automatic alert system was useful to identify, screen and isolate previous ESBLPE carriers. ESBLPE carriage was unexpectedly prolonged in Pts with short hospital stays. Recent years may be associated with shorter carriage. ABSTRACT Figure 1: Kaplan-Meier estimate of time until results of screenings for ESBLPE became negative for readmitted patients (%), Table 1: Variables associated with clearance of ESBLPE carriage using a Cox hazard proportional model K Bichat – Claude Bernard Hospital 46 rue Henri Huchard Paris Phone: Fax: Figure 2. Incidence of global ESBLPE cultured from screening or clinical samples, January 1997 to December 2010,